Background
Bacterial vaginosis is the most common cause of vaginal discharge in women of childbearing age, affecting nearly one in three women in the United States. 1 Bacterial vaginosis causes a wide range of consequences for these women, including a significant emotional burden and an increased risk for both adverse pregnancy outcomes and sexually transmitted infections.
Qualitative studies have linked bacterial vaginosis with women feeling dirty, embarrassed, ashamed, self-conscious, and frustrated over a lack of control over their symptoms, leading to negative consequences for themselves and their sexual relationships. 2, 3 These feelings often lead women to perform selfhygienic practices, including douching and use of fragrant soaps, lotions, and powders to try and gain some element of control over their condition. 4 Unfortunately, many of these practices may contribute to bacterial vaginosis or recurrence of symptoms. The medical consequences of bacterial vaginosis include higher rates of preterm birth in She was asymptomatic at the time of her evaluation including negative vaginal microscopy, pH, and whiff testing. She was advised to follow vulvar skin care guidelines, including avoidance of scented laundry, bathing, and cosmetic items.
She also began a trial of probiotics with Kefir.
Despite compliance with these measures, symptoms returned at approximately 2, 6, and 7 months following her initial appointment. On evaluation, she was found to have bacterial vaginosis each time, confirmed by clinical exam, microscopy, pH, and whiff testing. Oral metronidazole and oral fluconazole (prophylaxis) were prescribed for each encounter with reported symptom resolution. Following the 3 rd recurrent bacterial vaginosis episode, she received treatment with vaginal and vulvar 1% gentian violet painting, and was also advised to use vaginal 0.75% metronidazole vaginal gel prophylactically following intercourse and menses. Despite prophylaxis, she was diagnosed with bacterial vaginosis again 2 weeks and 2 months later.
Ten months following her initial referral to our center, she was diagnosed with Helicobacter pylori (H. pylori) following presentation with symptoms of nausea, abdominal pain, and weight loss. Symptoms had worsened acutely; however, she had a long history of gastro-esophageal reflux disease (GERD) poorly controlled with trials of histamine-receptor blockers and omeprazole. When found to be H. pylori antibody positive, she was treated with triple therapy consisting of amoxicillin, clarithromycin, and omeprazole, with confirmed eradication of the bacteria following therapy. Six months following triple therapy, she has remained clinically asymptomatic for bacterial vaginosis with no further prophylaxis or changes to her medical or sexual history.
Discussion

Recurrent bacterial vaginosis
Bacterial vaginosis occurs when bacterial species such as Gardnerella vaginalis, Atopobium vaginae, and Mobiluncus species replace the normal vaginal flora. 6 This alteration inhibits lactobacillus from maintaining a vaginal environment conducive to inhibiting
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infection with other bacteria and viruses. The mechanism by which the floral imbalance occurs and the role of sexual activity in the pathogenesis of bacterial vaginosis are not clear, but formation of an epithelial biofilm containing Gardnerella vaginalis appears to play an important role.
7,8 Bacterial vaginosis has often been associated with sexual activity, with multiple studies demonstrating associations between bacterial vaginosis and new sexual partners, multiple sexual partners, and lack of condom use. 9 While a significant risk factor, 15% of women with bacterial vaginosis deny any history of sexual intercourse. 1 Women who have sex with women are also at increased risk for bacterial vaginosis, with increased number of female partners showing a greater association. 10 Other risk factors for bacterial vaginosis include taking 4 or more baths in a week, having more than 2 live births, and douching. 11 Use of oral contraceptive pills appears to be protective.
The Center for Disease Control recommended treatment regimens include oral metronidazole 500 mg twice daily for 7 days, intravaginal 0.75% metronidazole gel for 5 days, or intravaginal 2% clindamycin cream for 7 days. 12 All 3 treatment modalities have been shown to have roughly equivalent effectiveness in curing bacterial vaginosis with similar rates of disease recurrence. 13 The recurrence rates following all treatments are high. One study following women treated with oral metronidazole found recurrence rates of 23% at 1 month post-treatment and 68% at 12 months post-treatment. 14 Several reasons have been suggested for this high rate of recurrence: failure of normal vaginal flora to take hold post treatment, reinfection through sexual encounters, antibiotic resistance, and the persistence of a polymicrobial vaginal biofilm. For these reasons, condom use is recommended for 3-6 months following treatment. 15 Evidence showing that treatment of sexual partners and recolonization with lactobacillus supplements is lacking. Prophylactic 0.75% metronidazole vaginal gel has been shown to prevent recurrence compared to placebo, but over half of women still have recurrent bacterial vaginosis at 28 weeks. 16 Also, a higher proportion of women treated with prophylactic metronidazole (43.1%) suffered from vulvovaginal candidiasis in this time period due to the effects of chronic antibiotic therapy.
Link between bacterial vaginosis and Helicobacter pylori?
Evidence linking H pylori infection with bacterial vaginosis is lacking; however, several theoretical links exist. H pylori has been shown to colonize yeast within the vagina and has also been associated with biofilm formation, making it possible that H pylori is one of many bacterial species seen in biofilms present in bacterial vaginosis leading to treatment failure. H pylori is commonly found in the stomach and upper gastrointestinal tract, one of the few bacteria able to colonize this acidic environment. 17 Eslick hypothesized that H pylori may be able to also colonize the acidic vaginal environment, acting as a reservoir and allowing sexual transmission of the bacteria.
H pylori isolates have also been found to have an endosymbiotic relationship with Candida albicans, with bacteria
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isolated from within these yeast. 18 This relationship may allow H pylori to colonize the vagina. Candida isolated from the vagina has been found to contain H pylori specific genes, one mechanism for the vertical transmission of H pylori. 19 The colonization of the vagina by H pylori may contribute to the high rates of treatment failure and infection recurrence in some women with bacterial vaginosis. 
